ProMetic Life Sciences News
Most Popular ProMetic Life Sciences Story
Abraxis, ProMetic ink $295M deal for four drugs
Abraxis has signed a $295M licensing deal with ProMetic Life Sciences to develop and market four biotech drugs. The companies didn't say which programs they woud be collaborating on, only that the... Read more...
Latest Headlines
- September 5, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
